Researchers Identify an Immunotherapy Target to Combat Glioblastomas
April 6, 2022 | Mindzilla
Houston, TX — Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common type of brain cancer in adults. Their in-depth molecular analysis of over 200,000 single cells revealed a protein, called S100A4, that could be a potential therapeutic target for restoring […]
You must be logged in to post a comment.